315 related articles for article (PubMed ID: 787905)
1. [Use of hemostatic preparations in obstetrical hemorrhages].
Pavlovskiĭ DP; Mikaĭlenko ET
Pediatr Akus Ginekol; 1976; (1):33-7. PubMed ID: 787905
[No Abstract] [Full Text] [Related]
2. [Hemostatic disorders in obstetrics and their correction].
Mikhaĭlenko ET; Pavlovskĭ DP
Pediatr Akus Ginekol; 1977; (2):33-8. PubMed ID: 329201
[No Abstract] [Full Text] [Related]
3. [Case contribution to the therapy of obstetrical afibrinogenemia].
Pleissner K
Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1297-9. PubMed ID: 5591403
[No Abstract] [Full Text] [Related]
4. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
Flähmig M; Sieg U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
[No Abstract] [Full Text] [Related]
5. Antifibrinolytics gynaecology and obstetrics.
Koutský J; Hladovec J
Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
[No Abstract] [Full Text] [Related]
6. [Thrombolytic treatment in pregnancy and during labor].
Brandt M; Niedner W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):477-82. PubMed ID: 63436
[No Abstract] [Full Text] [Related]
7. [Therapy of the disseminated intravascular coagulation syndrome in obstetrical practice].
Repina MA
Akush Ginekol (Mosk); 1979 Mar; (3):3-6. PubMed ID: 373481
[No Abstract] [Full Text] [Related]
8. [Management of blood coagulation disorders].
Porchia NL
Matern Infanc (Sao Paulo); 1968; 27(4):349-55. PubMed ID: 5728525
[No Abstract] [Full Text] [Related]
9. Clinical use of hemostatic agents.
Lowe GD; Lawson DH
J Maine Med Assoc; 1978 Mar; 69(3):87-97. PubMed ID: 650082
[No Abstract] [Full Text] [Related]
10. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology].
Koutský J
Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511
[No Abstract] [Full Text] [Related]
11. Fibrinogen concentrate use during major obstetric haemorrhage.
Glover NJ; Collis RE; Collins P
Anaesthesia; 2010 Dec; 65(12):1229-30. PubMed ID: 21182609
[No Abstract] [Full Text] [Related]
12. [Use of antifibrinolytic agents in obstetrics].
Vojta M
Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
[No Abstract] [Full Text] [Related]
13. [Hemorrhages caused by hyperfibrinolysis and their treatment].
Teofili MT; Tucci G
Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362
[No Abstract] [Full Text] [Related]
14. [Hemorrhagic complications caused by coagulation disorders in retention of the dead fetus].
Avanzini S; Orrù A; Malacrida V
Minerva Ginecol; 1969 Apr; 21(8):476-86. PubMed ID: 5306033
[No Abstract] [Full Text] [Related]
15. Amicar and hyperfibrinolysis.
Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
[No Abstract] [Full Text] [Related]
16. [The therapy of acute blood loss in puerperae].
Kuznetsov VP
Feldsher Akush; 1989 Dec; 54(12):5-7. PubMed ID: 2697599
[No Abstract] [Full Text] [Related]
17. [A contribution to diagnosis and therapy of blood coagulation during labor].
Burkhardt H; Schilling W
Zentralbl Gynakol; 1966 Feb; 88(6):145-53. PubMed ID: 5299035
[No Abstract] [Full Text] [Related]
18. [Different forms of utilization coagulopathy and their treatment].
Herschlein HJ; Steichele DF
Med Welt; 1969 Nov; 44():2389-98. PubMed ID: 4915798
[No Abstract] [Full Text] [Related]
19. [Fibrinolytic activity of peripheral and uterine blood as influenced by p-aminomethylbenzoic acid (PAMBA) in pgnancy toxemias].
Sieg U; Flähmig M
Zentralbl Gynakol; 1969 Dec; 91(51):1662-6. PubMed ID: 5383534
[No Abstract] [Full Text] [Related]
20. [Etiology, pathogenesis, and therapy of critical hemorrhages in pregnancy and during labor].
Appel W; Ardelt W
Zentralbl Gynakol; 1971 Feb; 93(8):241-50. PubMed ID: 5316218
[No Abstract] [Full Text] [Related]
[Next] [New Search]